Repairon’s groundbreaking regenerative heart failure therapy is being evaluated in a Phase 2 clinical study in Germany. As reported recently, an interim analysis presented at the 2025 Scientific ...

U.S. stocks extended losses with the Nasdaq leading the decline amid hotter producer prices, renewed tariff worries from Trump, and heavy selling in gold and tech shares, even as European markets ...

The major U.S. index futures are currently pointing to a lower open on Monday, with stocks likely to move to the downside following ...

(Alliance News) - UK annual house price growth rises more than expected in January, while AstraZeneca starts trading in New York and FitzWalter Capital says it does not intend to make an offer for ...

AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.

Build a $75K dividend portfolio around SCHD with a 5.67% yield and 5-year 5.60% dividend growth, plus VNQ/QQQI and top stocks. Click here to see the plan now.

Europe started the week on a bruising note. From Whitehall belt-tightening to Paris finally muscling a budget through ...

Lenzing Group has acquired a controlling majority stake in Swedish innovation company TreeToTextile AB through a share issuance, strengthening its position in sustainable, wood-based specialty fibers ...